News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
390,280 Results
Type
Article (30251)
Company Profile (149)
Press Release (359880)
Section
Business (101196)
Career Advice (650)
Deals (16536)
Drug Delivery (50)
Drug Development (63907)
Employer Resources (48)
FDA (11244)
Job Trends (8628)
News (191929)
Policy (16634)
Tag
Academia (1947)
Alliances (30214)
Alzheimer's disease (991)
Antibody-drug conjugate (ADC) (97)
Approvals (11211)
Artificial intelligence (142)
Bankruptcy (126)
Best Places to Work (7454)
Biotechnology (116)
Breast cancer (190)
Cancer (1521)
Career advice (548)
CAR-T (124)
Cell therapy (361)
Clinical research (51202)
Collaboration (485)
Compensation (137)
COVID-19 (1754)
C-suite (96)
Cystic fibrosis (88)
Data (1317)
Diabetes (99)
Diagnostics (4329)
Earnings (36134)
Events (57916)
Executive appointments (324)
FDA (11933)
Funding (380)
Gene therapy (221)
GLP-1 (387)
Government (2187)
Healthcare (11176)
Infectious disease (1819)
Inflammatory bowel disease (87)
Interviews (108)
IPO (8253)
Job creations (1496)
Job search strategy (459)
Layoffs (244)
Legal (2146)
Lung cancer (250)
Lymphoma (108)
Manufacturing (157)
Medical device (8586)
Medtech (8590)
Mergers & acquisitions (8519)
Metabolic disorders (302)
Neuroscience (1297)
NextGen: Class of 2025 (3523)
Non-profit (2235)
Northern California (1433)
Obesity (167)
Opinion (120)
Patents (86)
People (27794)
Phase I (17065)
Phase II (23155)
Phase III (16313)
Pipeline (522)
Postmarket research (1344)
Preclinical (7089)
Radiopharmaceuticals (157)
Rare diseases (274)
Real estate (3486)
Regulatory (13490)
Research institute (1875)
Resumes & cover letters (111)
Southern California (1167)
Startups (2083)
United States (12200)
Vaccines (374)
Weight loss (99)
Date
Today (103)
Last 7 days (424)
Last 30 days (1859)
Last 365 days (24948)
2025 (1864)
2024 (25242)
2023 (28191)
2022 (35062)
2021 (37067)
2020 (34244)
2019 (27374)
2018 (20628)
2017 (20688)
2016 (19164)
2015 (22554)
2014 (15830)
2013 (12800)
2012 (13272)
2011 (13543)
2010 (11584)
Location
Africa (343)
Asia (23515)
Australia (4527)
California (3179)
Canada (982)
China (289)
Colorado (132)
Connecticut (132)
Europe (52525)
Florida (434)
Georgia (115)
Illinois (222)
Indiana (152)
Maryland (498)
Massachusetts (2536)
Michigan (139)
Minnesota (204)
New Jersey (874)
New York (948)
North Carolina (532)
Northern California (1433)
Ohio (123)
Pennsylvania (716)
South America (504)
Southern California (1167)
Texas (468)
Utah (88)
Washington State (389)
390,280 Results for "cell design labs".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Zai Lab Receives Orphan Drug Designation from the U.S. FDA for ZL-1310 (DLL3 ADC) for the Treatment of Small Cell Lung Cancer (SCLC)
January 23, 2025
·
5 min read
Press Releases
Adaptimmune Announces U.S. FDA Breakthrough Therapy Designation Granted to Letetresgene Autoleucel (lete-cel) for Treatment of Myxoid/Round Cell Liposarcoma (MRCLS)
The Company will present at the Annual J.P. Morgan Healthcare Conference, providing business updates on its sarcoma franchise and other cell therapy pipeline assets Adaptimmune Allo-T program to be featured at the Biotech ShowCase(TM) and the Wuxi Global Forum 2025
January 13, 2025
·
5 min read
Press Releases
March Biosciences Receives FDA Orphan Drug Designation for MB-105, a First-in-Class CD5 CAR-T Cell Therapy, for T-Cell Lymphoma
January 28, 2025
·
3 min read
Press Releases
FDA Grants Orphan Drug Designation to IPS HEART’s GIVI-MPC Stem Cell Therapy for Becker Muscular Dystrophy
January 13, 2025
·
2 min read
Press Releases
European Commission Adopts Positive Decision for Orphan Medicinal Product Designation of Agios’ Mitapivat in Sickle Cell Disease
December 19, 2024
·
8 min read
Business
Portal Biotechnologies and Multiply Labs Announce Partnership to Automate Cell Engineering In Cell Therapy Manufacturing
Multiply Labs and Portal Biotechnologies announced their collaboration today, combining the efficiency of Multiply Labs’ robotic automation with the differentiated cell engineering capabilities of the Portal platform.
May 21, 2024
·
4 min read
Press Releases
JW Therapeutics Announces Receipt of Breakthrough Therapy Designation for Carteyva® in China as Second-line Treatment in Relapsed or Refractory adult Large B-cell Lymphoma
January 10, 2025
·
4 min read
Genetown
FDA Grants Orphan Drug Designation for BE-101, a Novel Engineered B Cell Medicine, for the Treatment of Hemophilia B
Be Biopharma, Inc. (“Be Bio”), a company pioneering the discovery and development of Engineered B Cell Medicines (BCMs), today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to BE-101, a novel engineered B Cell medicine (BCM) being developed for the treatment of Hemophilia B.
June 4, 2024
·
4 min read
Policy
SN Bioscience Receives FDA Fast Track Designation for Small Cell Lung Cancer
SN Bioscience Co. Ltd. announced on May 7 that the FDA has granted Fast Track Designation for small cell lung cancer for SNB-101, a new drug for polymer nanoparticle anticancer under clinical trial.
May 10, 2024
·
3 min read
Press Releases
U.S. FDA Grants Breakthrough Therapy Designation to Trodelvy® (sacituzumab govitecan-hziy) for Second-Line Treatment of Extensive-Stage Small Cell Lung Cancer
December 17, 2024
·
12 min read
1 of 39,028
Next
